Skip to Content
Merck
CN

SML3803

Gabapentin Enacarbil

≥95% (HPLC)

Synonym(s):

1-[[(1-(Isobutanoyloxy)ethoxy)carbonyl]aminomethyl]cyclohex-1-ylacetic acid, 1-[[[[1-(2-Methyl-1-oxopropoxy)ethoxy]carbonyl]amino]methyl]cyclohexaneacetic acid, XP 13512

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Empirical Formula (Hill Notation):
C16H27NO6
CAS Number:
Molecular Weight:
329.39
UNSPSC Code:
12352200
NACRES:
NA.21
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

SMILES string

N(CC1(CCCCC1)CC(=O)O)C(=O)OC(OC(=O)C(C)C)C

InChI

1S/C16H27NO6/c1-11(2)14(20)22-12(3)23-15(21)17-10-16(9-13(18)19)7-5-4-6-8-16/h11-12H,4-10H2,1-3H3,(H,17,21)(H,18,19)

InChI key

TZDUHAJSIBHXDL-UHFFFAOYSA-N

assay

≥95% (HPLC)

form

oil

color

, Faint yellow to dark yellow

storage temp.

2-8°C

Quality Level

Biochem/physiol Actions

Gabapentin enacarbil, a prodrug to gabapentin, is an orally available anticonvulsant and analgesic drug of the gabapentinoid class. Gabapentin enacarbil is used for treatment of restless legs syndrome.
Orally available anticonvulsant and analgesic drug; prodrug to gabapentin

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome
Advances in Pharmacology, 84, 187-205 (2019)
XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys
Journal of Pharmacology and Experimental Therapeutics, 311(1), 324-333 (2004)
Satomi Yamaguchi Ikeuchi et al.
Biological & pharmaceutical bulletin, 41(11), 1708-1715 (2018-11-02)
The purpose of this research was to establish an in vitro dissolution testing method to predict the oral pharmacokinetic (PK) profiles and food effects of gabapentin enacarbil formulated as wax matrix extended-release (ER) tablets in humans. We adopted various biorelevant

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service